Essais liés3clinical trials
VilleIstanbullocalisation
PaysTurkey (Türkiye)localisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06280209

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
NS-050/NCNP-03 Myopathies Phase 1/2 NCT06053814 NS-050/NCNP-03 in Boys With DMD (Meteor50) ACTIVE_NOT_RECRUITING
BMN 351 Myopathies Phase 1/2 NCT06280209 A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy ACTIVE_NOT_RECRUITING
BMN 351 Myopathies Phase 2 NCT07573631 An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy ENROLLING_BY_INVITATION